Last mentioned: Mar 23, 2026
Lead Plaintiff Deadline
The final date for investors to move the court to serve as lead plaintiff in the litigation.
Lead Plaintiff Deadline
Final date for affected investors to petition the court to lead the litigation.
Snowflake Filing
Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.
Trip.com Filing
Pomerantz LLP issues formal notice of class action filing against Trip.com Group Limited.
Gartner Filing
Pomerantz LLP issues formal notice of class action filing against Gartner, Inc.
Lawsuit Announcement
Kessler Topaz Meltzer & Check, LLP informs investors of the filed class action.
Lawsuit Publicized
Kessler Topaz informs investors of the filed securities fraud class action.
Class Period Ends
The final date of the alleged period of material misstatements and omissions.
Class Period Ends
Likely date of a corrective disclosure or regulatory event that impacted stock price.
Class Period Begins
The start date for investors eligible to join the securities fraud class action.
Class Period Begins
Start of the period during which Trip.com allegedly made misleading statements.
Trip.com Group Limited is the subject of a class-action lawsuit alleging material misstatements regarding its business practices and monopolistic activities between April 2024 and January 2026. Investors who suffered losses have until May 11, 2026, to seek lead plaintiff status in the litigation filed in the Eastern District of New York.
Trip.com Group Limited (NASDAQ: TCOM) is the target of a securities fraud class action lawsuit alleging material misstatements regarding its business practices and monopolistic activities. Investors who purchased securities between April 2024 and January 2026 have until May 11, 2026, to seek lead plaintiff status in the litigation.
Trip.com Group Limited (NASDAQ: TCOM) is facing a securities fraud class action lawsuit in the U.S. District Court for the Eastern District of New York. The litigation alleges the company made material misstatements and failed to disclose monopolistic business activities between April 2024 and January 2026.
Pomerantz LLP has initiated a series of class action filings against Gartner, Trip.com, and Snowflake, alleging violations of federal securities laws. These legal actions target corporate transparency and disclosure practices, signaling a heightened period of scrutiny for high-growth tech and consulting firms.
Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.
Pomerantz Law Firm has issued a formal reminder to Aquestive Therapeutics (AQST) investors regarding an ongoing class action lawsuit following a period of financial underperformance. The litigation coincides with a recent quarterly earnings miss and notable insider selling, creating a challenging regulatory and legal environment for the biotech firm.
Pomerantz Law Firm has issued urgent reminders to investors regarding upcoming lead plaintiff deadlines in class action lawsuits against Trip.com Group Limited, Driven Brands Holdings Inc., and Aquestive Therapeutics, Inc. These legal actions allege violations of federal securities laws, primarily focusing on misleading statements or omissions that resulted in significant financial losses for shareholders.